INS and metabolic dysfunction-associated steatohepatitis: To assess whether the dysbiosis observed in STAM mice, presumably due to decreased insulin action in the gut, was also relevant to patients with diabetes and NASH, we performed 16 S metagenomic analyses using fecal DNA samples of patients comorbid with diabetes and NASH.